Status:
COMPLETED
Medical Treatment of Early-Enamel Carious Lesion Using Different Remeneralizing Agents
Lead Sponsor:
Mansoura University
Conditions:
Enamel Caries
Eligibility:
All Genders
15-50 years
Phase:
NA
Brief Summary
Medical Treatment of Early-Enamel Carious Lesion using Different Remeneralizing agents
Detailed Description
Medical management of incipient lesions by application of remineralizing agents like fluoride therapy, amorphous calcium phosphate (ACP), and Casin phosphopeptide amorphous calcium phosphate (CPP-ACP)...
Eligibility Criteria
Inclusion
- Patients with early enamel lesions (ICDAS score 1 and 2).
- Patients with normal occlusion .
- Patients must have a good oral hygiene
- patients free from any systemic diseases and don't receive any medication
Exclusion
- smoker patients
- pregnant females
- patients with bad oral hygiene
- patients with enamel defects ( Amelogenesis Imperfecta, fluorosis, cracks or any developmental defects)
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2022
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05296213
Start Date
December 1 2019
End Date
January 10 2022
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kareem Hamdi
Al Mansurah, Egypt, 35111